ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Max Healthcare maintains strong momentum with 20% revenue growth, driven by rapid brownfield ramp-ups and improved ARPOB despite a 14% capacity increase.
Max Healthcare appointed Dharmender Kumar as Director and Chief - Public Affairs, effective November 1, 2026. The change was approved at the October 30, 2026 board meeting.
Max Healthcare will add 60 beds through two new floors at its Vaishali hospital. The Rs.97 Crore project is internally funded and due within 24 months.
Max Healthcare approved adding about 85 beds at its Noida hospital through redevelopment, at a cost of Rs 93 Crore funded by internal accruals. Commissioning is planned within 15 months.
Max Healthcare Q2 FY27 revenue rose to ₹3,219 Cr, up 20% YoY, with PAT at ₹448 Cr. Board approved ₹415 Cr capex for 209 additional beds.
Max Healthcare Institute Ltd reported revenue from operations of ₹2,569 Cr (+20.3% YoY) and net profit of ₹414.4 Cr (-15.7% YoY) for Q2 FY27.
Max Healthcare's NRC approved 95,000 ESOPs at ₹800 exercise price under its 2022 scheme. Vesting spans 1-5 years with a 3-year post-vesting exercise window.
Max Healthcare informed the Exchange that the NCLT hearing regarding petitions against its subsidiary, Kalinga Hospital Ltd., was adjourned to October 30, 2026.
Max Healthcare shareholders approved special resolutions by postal ballot on 19-Oct-2026. These cover a PRSU scheme for up to 73.5 lakh shares, remuneration for the Chairman and MD, and an alteration of the MoA objects clause.
Max Healthcare's board meets on 30-Oct-2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after results.
Max Healthcare Institute Limited has instituted the MHIL PRSU Scheme 2026. The scheme covers up to 73.50 lakh equity shares for employee stock-based incentives.
Max Healthcare Institute announced the postal ballot voting results. Shareholders approved the Performance Linked Restricted Stock Unit Scheme 2026 and other special resolutions.
Max Healthcare Institute Limited received an independent ESG rating of '66' from NSE Sustainability Ratings and Analytics. The rating for FY 2025-26 was assigned based on public disclosures.
Max Healthcare's CARE AA+ (Stable) long-term and A1+ short-term credit ratings on bank facilities are reaffirmed. No change in rating outlook or amounts.
Max Healthcare Institute Limited filed a Regulation 74(5) certificate confirming no dematerialization requests were received during the quarter ended September 30, 2026.
Max Healthcare's NCLT matter regarding BRS Capital was not heard on September 28, 2026, due to paucity of time. The hearing is adjourned to October 29, 2026.
Max Healthcare Institute Ltd issued a postal ballot notice to seek shareholder approval for its 2026 ESOP scheme, director remuneration, and alterations to its objects clause.
Max Healthcare has received an ESG rating of '72' from Niche99, a SEBI-registered provider. This independent rating places the company in the 'Leader' category.